Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients

Takuya Mikoshiba, Shin Saito, Yuichi Ikari, Nana Nakahara, Fumihiro Ito, Yoshihiro Watanabe, Mariko Sekimizu, Yorihisa Imanishi, Kaoru Ogawa, Hiroyuki Ozawa

Research output: Contribution to journalArticle

Abstract

Background: Induction chemotherapy (IC) for head and neck cancer (HNC) often causes severe side-effects. However, it has still been challenging to predict the adverse events. The present study aimed to evaluate the role of hematological inflammatory markers in predicting severe side-effects caused by IC. Materials and Methods: A total of 54 HNC patients who underwent IC were enrolled. The association between severe side-effects and pre-treatment hematological inflammatory markers [the C-reactive protein (CRP) to albumin ratio (CAR), the modified Glasgow Prognostic Score (mGPS), the neutrophil-to-lymphocyte ratio (NLR), and the platelet-to-lymphocyte ratio (PLR)] were evaluated. Results: In the univariate analysis, the incidence of whole severe side-effects (grade 4), febrile neutropenia (above grade 3), and hyponatremia (above grade 3) were significantly higher in the high CAR and high GPS groups. Multivariate analysis revealed that high CAR and mGPS were independent predictors of these side-effects. Conclusion: CAR and mGPS were significant predictors of severe side-effects. These data can potentially offer patients an improved quality of life during cancer therapy.

Original languageEnglish
Pages (from-to)3059-3065
Number of pages7
JournalAnticancer research
Volume39
Issue number6
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Induction Chemotherapy
Head and Neck Neoplasms
Albumins
Lymphocytes
Febrile Neutropenia
Hyponatremia
C-Reactive Protein
Neutrophils
Blood Platelets
Multivariate Analysis
Quality of Life
Incidence
Therapeutics
Neoplasms

Keywords

  • Hematological inflammatory markers
  • Inflammatory cytokines
  • Oropharyngeal and hypopharyngeal squamous cell carcinoma
  • Severe side-effect
  • TPF therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients. / Mikoshiba, Takuya; Saito, Shin; Ikari, Yuichi; Nakahara, Nana; Ito, Fumihiro; Watanabe, Yoshihiro; Sekimizu, Mariko; Imanishi, Yorihisa; Ogawa, Kaoru; Ozawa, Hiroyuki.

In: Anticancer research, Vol. 39, No. 6, 01.01.2019, p. 3059-3065.

Research output: Contribution to journalArticle

Mikoshiba, Takuya ; Saito, Shin ; Ikari, Yuichi ; Nakahara, Nana ; Ito, Fumihiro ; Watanabe, Yoshihiro ; Sekimizu, Mariko ; Imanishi, Yorihisa ; Ogawa, Kaoru ; Ozawa, Hiroyuki. / Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients. In: Anticancer research. 2019 ; Vol. 39, No. 6. pp. 3059-3065.
@article{f55a69a4c06d43828d2bc236687cbca0,
title = "Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients",
abstract = "Background: Induction chemotherapy (IC) for head and neck cancer (HNC) often causes severe side-effects. However, it has still been challenging to predict the adverse events. The present study aimed to evaluate the role of hematological inflammatory markers in predicting severe side-effects caused by IC. Materials and Methods: A total of 54 HNC patients who underwent IC were enrolled. The association between severe side-effects and pre-treatment hematological inflammatory markers [the C-reactive protein (CRP) to albumin ratio (CAR), the modified Glasgow Prognostic Score (mGPS), the neutrophil-to-lymphocyte ratio (NLR), and the platelet-to-lymphocyte ratio (PLR)] were evaluated. Results: In the univariate analysis, the incidence of whole severe side-effects (grade 4), febrile neutropenia (above grade 3), and hyponatremia (above grade 3) were significantly higher in the high CAR and high GPS groups. Multivariate analysis revealed that high CAR and mGPS were independent predictors of these side-effects. Conclusion: CAR and mGPS were significant predictors of severe side-effects. These data can potentially offer patients an improved quality of life during cancer therapy.",
keywords = "Hematological inflammatory markers, Inflammatory cytokines, Oropharyngeal and hypopharyngeal squamous cell carcinoma, Severe side-effect, TPF therapy",
author = "Takuya Mikoshiba and Shin Saito and Yuichi Ikari and Nana Nakahara and Fumihiro Ito and Yoshihiro Watanabe and Mariko Sekimizu and Yorihisa Imanishi and Kaoru Ogawa and Hiroyuki Ozawa",
year = "2019",
month = "1",
day = "1",
doi = "10.21873/anticanres.13440",
language = "English",
volume = "39",
pages = "3059--3065",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients

AU - Mikoshiba, Takuya

AU - Saito, Shin

AU - Ikari, Yuichi

AU - Nakahara, Nana

AU - Ito, Fumihiro

AU - Watanabe, Yoshihiro

AU - Sekimizu, Mariko

AU - Imanishi, Yorihisa

AU - Ogawa, Kaoru

AU - Ozawa, Hiroyuki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Induction chemotherapy (IC) for head and neck cancer (HNC) often causes severe side-effects. However, it has still been challenging to predict the adverse events. The present study aimed to evaluate the role of hematological inflammatory markers in predicting severe side-effects caused by IC. Materials and Methods: A total of 54 HNC patients who underwent IC were enrolled. The association between severe side-effects and pre-treatment hematological inflammatory markers [the C-reactive protein (CRP) to albumin ratio (CAR), the modified Glasgow Prognostic Score (mGPS), the neutrophil-to-lymphocyte ratio (NLR), and the platelet-to-lymphocyte ratio (PLR)] were evaluated. Results: In the univariate analysis, the incidence of whole severe side-effects (grade 4), febrile neutropenia (above grade 3), and hyponatremia (above grade 3) were significantly higher in the high CAR and high GPS groups. Multivariate analysis revealed that high CAR and mGPS were independent predictors of these side-effects. Conclusion: CAR and mGPS were significant predictors of severe side-effects. These data can potentially offer patients an improved quality of life during cancer therapy.

AB - Background: Induction chemotherapy (IC) for head and neck cancer (HNC) often causes severe side-effects. However, it has still been challenging to predict the adverse events. The present study aimed to evaluate the role of hematological inflammatory markers in predicting severe side-effects caused by IC. Materials and Methods: A total of 54 HNC patients who underwent IC were enrolled. The association between severe side-effects and pre-treatment hematological inflammatory markers [the C-reactive protein (CRP) to albumin ratio (CAR), the modified Glasgow Prognostic Score (mGPS), the neutrophil-to-lymphocyte ratio (NLR), and the platelet-to-lymphocyte ratio (PLR)] were evaluated. Results: In the univariate analysis, the incidence of whole severe side-effects (grade 4), febrile neutropenia (above grade 3), and hyponatremia (above grade 3) were significantly higher in the high CAR and high GPS groups. Multivariate analysis revealed that high CAR and mGPS were independent predictors of these side-effects. Conclusion: CAR and mGPS were significant predictors of severe side-effects. These data can potentially offer patients an improved quality of life during cancer therapy.

KW - Hematological inflammatory markers

KW - Inflammatory cytokines

KW - Oropharyngeal and hypopharyngeal squamous cell carcinoma

KW - Severe side-effect

KW - TPF therapy

UR - http://www.scopus.com/inward/record.url?scp=85067540888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067540888&partnerID=8YFLogxK

U2 - 10.21873/anticanres.13440

DO - 10.21873/anticanres.13440

M3 - Article

C2 - 31177149

AN - SCOPUS:85067540888

VL - 39

SP - 3059

EP - 3065

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -